Revenue segments as reported by the company.

Premiums

Product revenue

Administrative fees and other revenue

Net investment income

Net gains on financial instruments

Gain on sale of business

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit expense

Selling, general and administrative

Interest expense

Amortization of other intangible assets

Loss on extinguishment of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Elevance Health Inc

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The firm supports consumers, families, and communities across the entire care journey, connecting them to the care, support, and resources they need to lead healthier lives. It offers health plans and clinical, behavioral, pharmacy, and complex-care solutions which promote whole health. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Elevance Health reports robust Q4 earnings, eyes margin optimization

Elevance Health's strong Q4 2022 performance, strategic acquisitions, and focus on margin optimization position the company for continued growth. With a clear outlook for 2023, emphasizing membership expansion and margin recovery, the company is poised for success. Challenges in optimizing margins and managing cost structures are balanced by growth opportunities and strategic initiatives.

Elevance Health reports robust Q1 growth and innovation in healthcare

Elevance Health Inc demonstrated strong financial performance and growth in Q1 2023, driven by increased membership and solid operating results.
The company's focus on advocacy, innovation, and sustainability, along with strategic investments in healthcare capabilities, positions it for continued success.
While facing challenges in cost management and strategic partnerships, Elevance Health is well-positioned to capitalize on opportunities in specialty care and value-based models.
Overall, Elevance Health's commitment to whole health, innovation, and value-based care sets a positive trajectory for future growth and industry leadership.

Elevance Health Inc posts robust Q2 earnings, eyes value-based care

Elevance Health Inc reported strong Q2 earnings, raised adjusted EPS outlook to over $32.85 for the year, and emphasized a focus on value-based care and digital solutions. While facing margin pressure in Carelon, the company remains confident in its strategy execution and performance for 2023 and beyond.

Elevance Health excels in Q3, eyes growth through strategic actions

Elevance Health's Q3 performance was strong, with a focus on operational efficiency and strategic investments. Challenges in Medicare ratings were addressed through proactive measures, while opportunities lie in growth acceleration and strategic partnerships. The company remains on track to achieve its long-term growth targets.

Elevance Health Inc surpasses earnings expectations, eyes growth opportunities

Elevance Health Inc's strong financial performance in Q4 2023 and full-year results, coupled with strategic initiatives in expanding capabilities and enhancing operational efficiency, position the company for continued success. Challenges in commercial repricing and Medicaid dynamics are being addressed, while opportunities in Medicare Advantage and strategic investments offer avenues for growth.

Elevance Health posts robust Q1 earnings, eyes strategic growth

Elevance Health demonstrated strong financial performance in Q1, with revenue growth and margin expansion in key segments.
While facing challenges like potential Medicare rate cuts, the company is leveraging partnerships and acquisitions for growth.
Opportunities lie in expanding service offerings, geographic footprint, and optimizing Medicaid margins for long-term sustainability.

Elevance Health Inc reports robust earnings growth and strategic wins

Elevance Health's Q2 performance reflects strong earnings growth and reaffirmed guidance, driven by solid segment performance and new business wins.
The company's strengths lie in its high Medicare rating, robust revenue growth in services, and strategic focus on value creation.
Challenges include sustaining growth momentum, managing funding cuts, and effectively integrating recent acquisitions for long-term success.
Opportunities exist in accelerating capabilities, expanding market share, optimizing operations, and leveraging workplace recognition for talent attraction and innovation.

Elevance Health faces Medicaid challenges, sees growth in AI investments

Elevance Health's Q3 earnings were impacted by elevated medical costs in Medicaid, leading to a reduction in full-year outlook. Despite challenges in the Medicaid business, the company's Medicare Advantage and Commercial businesses are performing well. Investments in AI and expansion of Carelon Services present growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

The health insurer has made shareholders much richer over the last decade.

This Dividend Stock Could Be a Superb Wealth Compounder

American Tower

Cigna

Estee Lauder

ServiceNow

Prologis

S&P Global

Thermo Fisher Scientific

Visa

Zoetis

Institutional investors are big investors that generally buy shares on behalf of their clients or members.

These Are The Ten Biggest Companies With Over 90% Institutional Ownership

BETHESDA, Md. & INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, (NYSE: ELV), one of the nation's leading health companies, and Aledade, an innovative primary care physician enablement company, today announced a partnership that will help enhance the consumer experience and health outcomes for those seeking services from independent primary care practices. The partnership centers on assisting independent primary care physicians across the country transition to value-based care, which is proven t

Elevance Health and Aledade Partner to Advance Value-Based Care Nationwide

Elevance Health (ELV) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Why Elevance Health (ELV) Is a Great Growth Stock

MetLife

News Corp

T. Rowe Price Group

UnitedHealth Group

T Rowe Price Equity Income Fund (Trades, Portfolio), part of Baltimore-based T. Rowe Price Group Inc. ( TROW , Financial), disclosed that its top five trades during the second quarter included a new position in Meta Platforms Inc. ( META , Financial), a boost to its holding in News Corp. ( NWSA , Financial), the closure of its stake in UnitedHealth Group Inc. ( UNH , Financial) and reductions to its positions in MetLife Inc. ( MET , Financial) and Elevance Health Inc. ( ELV , Financial).

T Rowe Price Equity Income Fund Enters Meta Position in 2nd Quarter

GoodRx Holdings

ELV vs. GDRX: Which Stock Is the Better Value Option?

ELV vs. GDRX: Which Stock Should Value Investors Buy Now?

Here is how Elevance Health (ELV) and HealthEquity (HQY) have performed compared to their sector so far this year.

Has Elevance Health, Inc. (ELV) Outpaced Other Medical Stocks This Year?

Elevance Health (ELV) hikes adjusted net income estimate for this year to more than $28.70 per share.

Elevance Health (ELV) Q2 Earnings Beat on Higher Premiums

Shares of Elevance Health Inc. ELV, -8.54% , previously known as Anthem Inc, tumbled 8.7% in afternoon trading Wednesday, enough to pace the S&P 500's SPX, +0.27% decliners, as investors jeered the health insurance company's second-quarter results. The stock was on track to suffer the biggest one-day selloff since March 2020.

Elevance Health stock drops to lead S&P 500 losers as earnings 'beat and raise' missed high expectations

Elevance Health Inc. (ELV) CEO Gail Boudreaux on Q2 2022 Results - Earnings Call Transcript

Anthem (ELV) delivered earnings and revenue surprises of 4.15% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Anthem (ELV) Surpasses Q2 Earnings and Revenue Estimates

INDIANAPOLIS--(BUSINESS WIRE)---- $ELV #earnings--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share. "The disciplined execution of our strategy, and the balance and resilience of our diversified portfolio of businesses has enabled us to deliver another quarter of strong organic growth, and we have raised our outlook for 2022 earnings per share as a result," sa

Elevance Health Reports Second Quarter 2022 Results, Raises Full Year Outlook

Elevance Health's (ELV) second-quarter results are likely to reflect improved Commercial Business operations, driven by the robust growth in risk-based areas.

Can Elevance Health (ELV) Beat Q2 Earnings on Membership Growth?

Anthem (ELV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Anthem (ELV) Earnings Expected to Grow: Should You Buy?

AMN Healthcare Services

DaVita

HCA Healthcare

U.S. market indexes kicked off the week lower as investors prepare for the start of second-quarter earnings season.

5 Undervalued Predictable Health Care Stocks

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 866-430-8797 (Domestic Replay) 312-470-0178 (International) 203-369-0943 (Internati

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 20, 2022

INDIANAPOLIS--(BUSINESS WIRE)-- #earnings--President and CEO Gail K. Boudreaux celebrates Elevance Health's official rebranding with the ringing of the opening bell at the New York Stock Exchange. Joining Boudreaux are members of the board of directors and the company's senior leadership team. The company will now trade under the ticker symbol “ELV.” About Elevance Health, Inc. Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company support

News for Elevance Health Inc Stock (ELV)